Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Sep 5 2021 | Heart Failure Awareness 365: Resources for New HF Patients Patient News Heart Failure Awareness 365 Patient Resource Read More Sep 1 2021 | HFSA Releases Scientific Statement on the Intersection of COVID-19 and Heart Failure HFSA News Coronavirus Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More Aug 27 2021 | AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19 Industry News Industry Read More Aug 27 2021 | Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction Industry News Industry Read More Aug 27 2021 | HFSA Announces Late Breaking Clinical Trials Coming to HFSA 2021 HFSA News Annual Scientific Meeting Read More Pagination First page « First Previous page ‹ Previous … Page 74 Page 75 Page 76 Page 77 Current page 78 Page 79 Page 80 Page 81 Page 82 … Next page Next › Last page Last »
Sep 5 2021 | Heart Failure Awareness 365: Resources for New HF Patients Patient News Heart Failure Awareness 365 Patient Resource Read More
Sep 1 2021 | HFSA Releases Scientific Statement on the Intersection of COVID-19 and Heart Failure HFSA News Coronavirus Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More
Aug 27 2021 | AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19 Industry News Industry Read More
Aug 27 2021 | Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction Industry News Industry Read More
Aug 27 2021 | HFSA Announces Late Breaking Clinical Trials Coming to HFSA 2021 HFSA News Annual Scientific Meeting Read More
